1. Introduction {#sec1-molecules-21-00968}
===============

*Nauclea officinalis* Pierre ex Pitard belongs to the genus *Nauclea* in family Rubiaceae, which is mainly distributed in Hainan, Guangxi, Guangdong and other provinces in the south of China. As a traditional Chinese medicine, the bark and twigs of *N*. *officinalis* is widely used for the treatment of colds, fever, acute tonsillitis, sore throat, conjunctivitis, enteritis, dysentery, eczema and other ailments \[[@B1-molecules-21-00968]\]. Previous phytochemical investigation had revealed that monoterpene indole alkaloids, which present a polycyclic skeleton with a tetrahydro-β-carboline ring, are the main components of this plant \[[@B2-molecules-21-00968],[@B3-molecules-21-00968],[@B4-molecules-21-00968],[@B5-molecules-21-00968],[@B6-molecules-21-00968],[@B7-molecules-21-00968],[@B8-molecules-21-00968],[@B9-molecules-21-00968],[@B10-molecules-21-00968],[@B11-molecules-21-00968],[@B12-molecules-21-00968],[@B13-molecules-21-00968]\]. The complex ring system and diversity of stereostructure of these monoterpene indole alkaloids have attracted great interest for phytochemical studies. As a part of our ongoing program to search for structurally unique alkaloids from the medicinal plants in southern China \[[@B5-molecules-21-00968],[@B13-molecules-21-00968]\], we carried out the continuing investigation on the leaves of *N*. *officinalis*. In our present study, three new indole alkaloids, naucleamide G (**1**), and nauclealomide B and C (**5** and **6**), together with three known ones, paratunamide C (**2**), paratunamide D (**3**) and paratunamide A (**4**) ([Figure 1](#molecules-21-00968-f001){ref-type="fig"}), were isolated, among which oxindole alkaloids (**2**--**6**) were rarely reported from the *Nauclea* genus. In this paper, we describe the structure elucidation of these new alkaloids by means of NMR, HRESIMS, circular dichroism spectroscopy and computational analysis.

2. Results and Discussion {#sec2-molecules-21-00968}
=========================

Compound **1** showed a molecular formula of C~20~H~22~N~2~O~3~ based on the HRESIMS (*m*/*z* 339.1703 \[M + H\]^+^; calculated for C~20~H~23~N~2~O~3~: *m*/*z* 339.1709). The UV spectrum of **1** showed absorption maxima at 211 and 290 nm. The IR spectrum exhibited absorptions at 3373 and 1636 cm^−1^, which suggested the presence of amino and α, β-unsaturated carbonyl functional groups. The ^1^H-NMR spectrum of **1** displayed four aromatic protons (δ~H~ 7.46 (1H, d, *J* = 8.0 Hz), 7.37 (1H, d, *J* = 8.0 Hz), 7.12 (1H, t, *J =* 8.0 Hz) and 7.00 (1H, t, *J =* 8.0 Hz)), three terminal vinyl protons (δ~H~ 6.39 (1H, ddd, *J =* 17.3, 10.4, 7.3 Hz), 5.28 (1H, d, *J =* 17.3 Hz) and 5.23 (1H, d, *J =* 10.4 Hz)) and one amino proton (δ~H~ 11.19 (1H, s)). The ^13^C-NMR and DEPT spectra of **1** displayed 20 signals, including six methylenes, eight methines, one carbonyl, and five quaternary carbons, suggesting the presence of a monoterpene indole alkaloid.

With the aid of Two Dimensional ^1^H Correlation Spectroscopy (^1^H-^1^H COSY), ^1^H-Detected Heteronuclear Single Quantum Correlation (HSQC), 1H-Detected Heteronuclear Multiple Bond Correlation (HMBC), and Rotating-frame Overhauser Enhancement Spectroscopy (ROESY) experiments, all of the ^1^H and ^13^C-NMR signals of **1** were assigned as shown in [Table 1](#molecules-21-00968-t001){ref-type="table"}. The ^1^H-^1^H COSY spectrum of **1** revealed the presence of three spin coupling systems (δ~H~ 7.46 (H-9)↔7.00 (H-10)↔7.12 (H-11)↔7.37 (H-12), δ~H~ 4.80 (Ha-5)↔2.61 (Hb-6) and δ~H~ 5.28 (Ha-18)/5.23 (Hb-18)↔6.39 (H-19)↔2.51 (H-20)↔2.33 (H-15)↔2.79 (H-16)↔4.08 (Ha-17)/3.65 (Hb-17)↔4.69 (H-OH), 2.33 (H-15)↔1.72 (Hb-14), 2.51 (H-20)↔3.59 (Hb-21)). In the HMBC spectrum, the correlations between H-1 (δ~H~ 11.19) and C-7 (δ~C~ 108.7)/C-8 (δ~C~ 125.3)/C-2 (δ~C~ 133.8)/C-13 (δ~C~ 136.2), between H-9 (δ~H~ 7.46) and C-7 (δ~C~ 108.7)/C-13 (δ~C~ 136.2), between H-12 (δ~H~ 7.37) and C-8 (δ~C~ 125.3), between Ha-5 (δ~H~ 4.80) and C-3 (δ~C~ 80.9)/C-7 (δ~C~ 108.7), as well as between Ha-6 (δ~H~ 2.74)/Hb-6 (δ~H~ 2.61) and C-2 (δ~C~ 133.8) revealed the presence of a tetrahydro-β-carboline ring. In addition, the correlations between Ha-5 (δ~H~ 4.80) and C-22 (δ~C~ 170.6), between Ha-14 (δ~H~ 2.89) and C-2 (δ~C~ 133.8), between Ha-21 (δ~H~ 3.66)/Hb-21 (δ~H~ 3.59)/Ha-14 (δ~H~ 2.89)/Hb-14 (δ~H~ 1.72)/H-15 (δ~H~ 2.33) and C-3 (δ~C~ 80.9), as well as between H-15 (δ~H~ 2.33)/Ha-17 (δ~H~ 4.08)/Hb-17 (δ~H~ 3.65) and C-22 (δ~C~ 170.6) revealed the presence of ring D, which was fused to the tetrahydro-β-carboline ring and ring E ([Figure 2](#molecules-21-00968-f002){ref-type="fig"}).

The relative configuration of **1** was deduced from coupling constants and ROESY data. The coupling constants of ^3^*J*~14a,15~ *=* 3.3 Hz, ^3^*J*~14b,15~ = 2.0 Hz and ^3^*J*~15,16~ \< 1.0 Hz, and the ROESY correlations between Hb-21 and H-16, as well as between H-15 and Ha-17/Hb-17 indicated both chair conformations of rings D and E, a cis-ring junction between rings D and E, and different orientations of H-15 and H-16 \[[@B14-molecules-21-00968]\]. In addition, the ROESY correlations between H-19 and Ha-14/H-15 suggested different orientations of H-15 and H-20. On the basis of the above results, the relative configuration of **1** was elucidated as shown in [Figure 3](#molecules-21-00968-f003){ref-type="fig"}. The absolute configuration of **1** was confirmed by the quantum chemical CD calculation method at the (B3LYP/6-31G(d)) level using the GAUSSIAN 09 program, and the calculated CD curve of 3*R*,15*S*,16*R*,20*R*-**1** was similar to the measured spectrum ([Figure 4](#molecules-21-00968-f004){ref-type="fig"}). Therefore, the structure of **1** was established and named naucleamide G.

Compounds **5** and **6** showed the same molecular formula C~26~H~30~N~2~O~10~ as nauclealomide A by their HRESIMS (*m*/*z* 553.1782 \[M + Na\]^+^ and 553.1783 \[M + Na\]^+^). Moreover, the ^1^H and ^13^C-NMR data of **5** and **6** were similar to those of nauclealomide A ([Table 2](#molecules-21-00968-t002){ref-type="table"}). Thus, the planar structures of **5**, **6** were identical to that of nauclealomide A ([Figure 1](#molecules-21-00968-f001){ref-type="fig"}) \[[@B13-molecules-21-00968]\]. The coupling constants of ^3^*J*~20,21~ (*J* = 1.7 Hz) and ^3^*J*~20,15~ (*J* = 5.8 Hz) suggested the presence of β/β/α orientation for H-15, H-20 and H-21 in **5** and **6** \[[@B15-molecules-21-00968],[@B16-molecules-21-00968],[@B17-molecules-21-00968]\].

In the ^1^H-NMR spectrum of **5**, the coupling constants of ^3^*J*~3,14a~ (*J* = 9.5 Hz) and ^3^*J*~3,14b~ (*J* = 4.6 Hz) indicated the presence of β configuration of H-3, which was confirmed by the ROESY correlation between H-3 and H-15. In the ROESY spectrum, the correlations between H-3 and Hb-5/Hb-6, as well as between H-9 and Ha-5/Ha-6 indicated the presence of α/β/α/β configuration of Ha-5, Hb-5, Ha-6 and Hb-6 ([Figure 3](#molecules-21-00968-f003){ref-type="fig"}). The absolute configuration of C-15 in these indole alkaloids was determined as *S* biosynthetically based on secologanin ([Scheme 1](#molecules-21-00968-sch001){ref-type="scheme"}). Thus, the absolute configuration of **5** was elucidated as 3*S*, 7*S*, 15*S*, 20*R*, 21*S*.

In the ^1^H-NMR spectrum of **6**, the coupling constants of ^3^*J*~3,14a~ (*J* = 3.6 Hz) and ^3^*J*~3,14b~ (*J* = 2.1 Hz) indicated the presence of *α* configuration of H-3. In the ROESY spectrum, the correlation between H-3 and H-9 was observed, which suggested that the carbonyl group at C-2 was above the C/D/E plane ([Figure 3](#molecules-21-00968-f003){ref-type="fig"}). Considering the biogenetic pathway for these indole alkaloids, the absolute configuration of C-15 was determined as *S*. Thus, the absolute configuration of **6** was elucidated as 3*R*, 7*S*, 15*S*, 20*R*, 21*S*.

The three known indole alkaloids were identified as paratunamide C (**2**) \[[@B18-molecules-21-00968]\], paratunamide D (**3**) \[[@B18-molecules-21-00968]\], and paratunamide A (**4**) \[[@B18-molecules-21-00968]\] by comparison of their spectroscopic data with those reported in the literature.

Based on the structural features of compounds **1**--**6**, which were all derived from [l]{.smallcaps}-tryptophan and secologanin, the plausible biosynthetic pathway for them was deduced ([Scheme 1](#molecules-21-00968-sch001){ref-type="scheme"}).

3. Materials and Methods {#sec3-molecules-21-00968}
========================

3.1. General Procedures {#sec3dot1-molecules-21-00968}
-----------------------

Optical rotations were measured on a JASCO P-1020 polarimeter (JASCO Corporation, Tokyo, Japan). UV spectra were recorded on a JASCO V-550 UV/VIS spectrophotometer (JASCO Corporation). A JASCO FT/IR-480 plus FT-IR spectrometer (JASCO Corporation) was used for scanning the IR spectra with KBr pellets. ^1^H, ^13^C, and 2D NMR spectra were recorded on a Bruker AV-400 spectrometer (Bruker Corporation, Rheinstetten, Germany). HR-ESI-MS data were conducted on an Agilent 6210 LC/MSD TOF mass spectrometer. CD spectra were obtained using a JASCO J-810 circular dichroism spectrometer. For column chromatography, silica gel (300--400 mesh; Qingdao Marine Chemical Group Corporation, Qingdao, China) and Sephadex LH-20 (Pharmacia, Pittsburgh, PA, USA) were used. TLC analyses were carried out using precoated silica gel GF~254~ plates (Yantai Chemical Industry Research Institute, Yantai, China). Analytic high-performance liquid chromatography (HPLC) was performed on a SHIMADZU chromatography (SHIMADZU Corporation, Kyoto, Japan) equipped with an LC-20AD pump and an SPD-M20A diode-array detector (DAD) with an Inertsil ODS-3 column (4.6 mm × 250 mm, 5 μm). Preparative HPLC was carried out on a SHIMADZU instrument equipped with an LC-20AP pump and an SPD-20A (SHIMADZU Corporation) detector with a YMC-Pack ODS-A column (20 mm × 250 mm, 5 μm).

3.2. Plant Material {#sec3dot2-molecules-21-00968}
-------------------

The leaves of *N. officinalis* were collected in Sanya City, Hainan Province, China, in July 2008, and authenticated by Professor Wei-ping Chen (Hainan Branch Institute of Medicinal Plants, Chinese Academy of Medical Science, Haikou, China). A voucher specimen (No. 20090223) was deposited in the Institute of Traditional Chinese Medicine and Natural Products, Jinan University, Guangzhou, China.

3.3. Extraction and Isolation {#sec3dot3-molecules-21-00968}
-----------------------------

Air-dried and powdered leaves of *N*. *officinalis* (4.8 kg) were extracted with 95% EtOH (50 L × 3, 3 days each) at room temperature. The EtOH solution was evaporated under reduced pressure to afford a residue (250.0 g), which was suspended in water and partitioned successively with light petroleum, EtOAc and *n*-BuOH. The *n*-BuOH fraction (60.0 g) was subjected to silica gel CC, eluting with CHCl~3~-MeOH (100:0→0:100) to give nine fractions (Fr. 1--9). Fr. 1 (5.0 g) was separated by a silica gel column with CHCl~3~-MeOH (95:5) as the eluent to give fifteen subfractions (Fr. 1-1--Fr. 1-15). Fr. 1--2 (90.0 mg) was subsequently purified by a Sephadex LH-20 column eluted with MeOH to yield compounds **1** (5.0 mg). Fr. 7 (1.0 g) was further purified on a Sephadex LH-20 column using MeOH as eluent, then compounds **2** (22.0 mg), **3** (32.0 mg), **4** (17.0 mg), **5** (12.0 mg) and **6** (8.0 mg) were finally obtained by preparative HPLC using MeOH-H~2~O (40:60, 8 mL/min) as the mobile phase.

3.4. Compound Characterization {#sec3dot4-molecules-21-00968}
------------------------------

*Naucleamide G* (**1**): orange amorphous powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −28.8 (*c* 0.18, MeOH); UV (MeOH) λ~max~ (log *ε*): 211 (4.11), 290 (3.52) nm; IR (KBr): *ν*~max~ 3373, 1692, 1636, 1409, 1174 cm^−1^; HR-ESI-MS *m*/*z*: 339.1703 \[M + H\]^+^ (calcd for C~20~H~23~N~2~O~3~, 339.1709); ^1^H-NMR (DMSO-*d*~6~, 400 MHz) and ^13^C-NMR (DMSO-*d*~6~, 100 MHz), see [Table 1](#molecules-21-00968-t001){ref-type="table"} and [Supplementary Materials](#app1-molecules-21-00968){ref-type="app"}.

*Nauclealomide B* (**5**): yellowish amorphous solid; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{27}$ −269 (*c* 0.25, MeOH); UV (MeOH) λ~max~(log *ε*): 211 (4.31), 243 (4.12) nm; IR (KBr) *ν*~max~: 3417, 1713, 1657, 1473, 1067 cm^−1^; HR-ESI-MS *m*/*z*: 553.1782 \[M + Na\]^+^ (calcd for C~26~H~30~N~2~O~10~Na, 553.1793); ^1^H-NMR (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz), see [Table 2](#molecules-21-00968-t002){ref-type="table"}.

*Nauclealomide C* (**6**): yellowish amorphous solid; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{27}$ −117 (*c* 0.17, MeOH); UV (MeOH) λ~max~ (log *ε*): 212 (4.33), 242 (4.10) nm; IR (KBr) *ν*~max~: 3404, 1733, 1669, 1475, 1061 cm^−1^; HR-ESI-MS *m*/*z*: 553.1783 \[M + Na\]^+^ (calcd for C~26~H~30~N~2~O~10~Na, 553.1793); ^1^H-NMR (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz), see [Table 2](#molecules-21-00968-t002){ref-type="table"}.

3.5. Acid Hydrolysis and Sugar Analysis {#sec3dot5-molecules-21-00968}
---------------------------------------

Each solution of compounds **5** and **6** (2 mg each) in 2 mol/L HCl (5 mL) was hydrolyzed at 80 °C for 2 h. The solution was then evaporated under reduced pressure. The residue was dissolved in 1 mL of pyridine containing 2 mg of [l]{.smallcaps}-cysteine methyl ester hydrochloride, after which the reaction mixture was heated at 60 °C for 1 h. *O*-tolyl isothiocyanate (5 μL) was then added to the mixture and heated at 60 °C for an additional 1 h. The reaction mixture was subsequently analyzed by HPLC and detected at 250 nm. Analytical HPLC was performed on an Inertsil ODS-3 column (4.6 × 250 mm, 5 μm) at 20 °C using CH~3~CN-0.05% CH~3~COOH in H~2~O (25:75, 1.0 mL/min) as the mobile phase. Peaks were detected with an SPD-M20A DAD. D-Glucose (*t*~R~ 16.4 min) was identified as the sugar moiety of indole alkaloids **5** and **6** by comparison with authentic samples of [d]{.smallcaps}-glucose (*t*~R~ 16.4 min) and [l]{.smallcaps}-glucose (*t*~R~ 14.9 min) \[[@B19-molecules-21-00968]\].

4. Conclusions {#sec4-molecules-21-00968}
==============

Six indole alkaloids, including three new ones **1**, **5** and **6**, named naucleamide G, and nauclealomide B and C, were isolated from the *n*-BuOH-soluble fraction of an EtOH extract of the leaves of *N*. *officinalis*. The structures and absolute configurations of the new indole alkaloids were elucidated by means of NMR, HRESIMS, acid hydrolysis and quantum chemical CD calculation. Compounds **2**--**4** were isolated from the *Nauclea* genus for the first time and oxindole alkaloids (**2**--**6**) were rare in this genus. Thus, the findings complemented previous reports of the occurrence of indole alkaloids in the *Nauclea* genus and might be a useful chemotaxonomic marker of this genus. In addition, a plausible biosynthetic pathway for all the alkaloids was proposed. Compound **1** with a tetrahydro-β-carboline ring originated from condensation of [l]{.smallcaps}-tryptophan with secologanin to give strictosidine; nevertheless, oxindole alkaloids (**2**--**6**) might be generated through another biosynthetic route.
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![Structures of compounds **1**--**6** isolated from *N*. *officinalis*, as well as structure of nauclealomide A mentioned in the text.](molecules-21-00968-g001){#molecules-21-00968-f001}

![^1^H-^1^H COSY and key HMBC correlations of **1**.](molecules-21-00968-g002){#molecules-21-00968-f002}

![Selected ROESY correlations of **1**, **5** and **6**.](molecules-21-00968-g003){#molecules-21-00968-f003}

![Calculated and experimental CD spectra of **1**.](molecules-21-00968-g004){#molecules-21-00968-f004}

![The plausible biosynthetic pathway for **1**--**6**.](molecules-21-00968-sch001){#molecules-21-00968-sch001}
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###### 

^1^H (400 MHz) and ^13^C (100 MHz) NMR data of **1** (dimethylsulfoxide-*d*~6~ (DMSO-*d*~6~), δ in ppm, *J* in Hz).

  Position                δ~C~    δ~H~
  ----------------------- ------- ----------------------------
  1                       \-      11.19 s
  2                       133.8   \-
  3                       80.9    \-
  5                       34.6    a 4.80 dd (12.7, 4.7)
  b 2.82 m                        
  6                       20.7    a 2.74 m
  b 2.61 m                        
  7                       108.7   \-
  8                       125.3   \-
  9                       118.6   7.46 d (8.0)
  10                      118.7   7.00 t (8.0)
  11                      121.9   7.12 t (8.0)
  12                      111.5   7.37 d (8.0)
  13                      136.2   \-
  14                      31.5    a 2.89 dd (13.0, 3.3)
  b 1.72 dd (13.0, 2.0)           
  15                      30.9    2.33 br s
  16                      46.8    2.79 m
  17                      58.9    a 4.08 m
  b 3.65 m                        
  17-OH                   \-      4.69 dd (6.0, 4.3)
  18                      115.5   a 5.28 d (17.3)
  b 5.23 d (10.4)                 
  19                      140.4   6.39 ddd (17.3, 10.4, 7.3)
  20                      35.8    2.51 m
  21                      61.7    a 3.66 m
  b 3.59 dd (12.7, 3.1)           
  22                      170.6   \-

molecules-21-00968-t002_Table 2

###### 

^1^H (400 MHz) and ^13^C (100 MHz) NMR data of nauclealomide A, **5** and **6** (CD~3~OD, δ in ppm, *J* in Hz).

  Position                Nauclealomide A                5                             6                                              
  ----------------------- ------------------------------ ----------------------------- ------- ------------------------------ ------- -----------------------------
  2                       180.1                          \-                            179.5   \-                             177.8   \-
  3                       80.0                           6.28 t (2.8)                  80.4    6.04 dd (9.5, 4.6)             81.2    5.72 dd (3.6, 2.1)
  5                       39.3                           a 4.60 ddd (13.0, 4.9, 1.8)   36.1    a 4.43 dt (13.3, 4.7)          39.7    a 4.73 ddd (13.6, 5.4, 2.8)
  b 3.75 dd (13.0, 3.0)   b 3.73 ddd (13.3, 11.0, 3.7)   b 3.55 td (13.6, 3.3)                                                        
  6                       32.4                           a 2.11 td (14.1, 5.4)         31.7    a 2.16 ddd (14.2, 11.0, 4.9)   31.3    a 2.17 td (13.3, 5.6)
  b 1.77 m                b 2.03 dt (14.2, 4.0)          b 1.67 m                                                                     
  7                       77.6                           \-                            76.3    \-                             79.4    \-
  8                       131.4                          \-                            131.5   \-                             131.6   \-
  9                       125.4                          7.25 br d (7.5)               125.1   7.27 br d (7.7)                126.6   7.82 br d (7.6)
  10                      123.9                          7.02 br t (7.5)               123.9   7.00 td (7.7, 1.1)             123.7   7.07 td (7.6, 0.9)
  11                      131.1                          7.25 br t (7.5)               131.2   7.24 td (7.7, 1.1)             131.1   7.31 td (7.6, 0.9)
  12                      111.0                          6.84 br d (7.5)               111.2   6.85 br d (7.7)                111.9   6.94 br d (7.6)
  13                      142.3                          \-                            142.4   \-                             142.6   \-
  14                      29.7                           1.76 m                        32.2    a 1.45 dt (13.9, 9.5)          29.9    a 1.78 td (14.0, 3.6)
  b 1.95 dt (12.9, 4.6)   b 1.71 m                                                                                                    
  15                      23.4                           3.27 m                        24.4    3.02 m                         23.5    3.34 m
  16                      109.0                          \-                            109.1   \-                             109.2   \-
  17                      149.7                          7.44 d (2.4)                  149.1   7.40 d (2.3)                   149.5   7.42 d (2.4)
  18                      120.7                          a 5.29 dd (12.1, 1.6)         120.7   5.24 dd (14.5, 1.6)            120.6   5.22 m
  b 5.24 td (5.2, 1.8)    5.21 dd (7.8, 1.8)                                                                                          
  19                      134.1                          5.56 dt (17.2, 10.1)          133.8   5.53 dt (17.2, 10.0)           134.0   5.54 dt (17.6, 9.8)
  20                      44.3                           2.61 ddd (10.1, 5.8, 1.7)     44.4    2.60 ddd (10.0, 5.8, 1.7)      44.2    2.56 ddd (9.8, 5.8, 1.7)
  21                      98.1                           5.46 d (1.7)                  97.3    5.47 d (1.7)                   97.6    5.45 d (1.7)
  22                      166.1                          \-                            165.7   \-                             166.1   \-
  1'                      100.4                          4.69 d (7.9)                  99.6    4.65 d (7.9)                   100.0   4.66 d (7.8)
  2'                      74.7                           3.20 m                        74.6    3.18 dd (8.9, 7.9)             74.6    3.24 dd (9.0, 7.8)
  3'                      78.2                           3.37 m                        77.8    3.36 m                         77.7    3.39 m
  4'                      71.5                           3.30 m                        71.5    3.30 m                         71.5    3.31 m
  5'                      78.3                           3.31 m                        78.2    3.31 m                         78.3    3.31 m
  6'                      62.6                           a 3.87 dd (11.8, 1.7)         62.6    a 3.87 dd (11.9, 1.6)          62.7    a 3.88 dd (11.9, 1.6)
  b 3.66 dd (11.8, 5.3)   b 3.66 dd (11.9, 5.4)          b 3.67 dd (11.9, 5.3)                                                        
